The most common test for the detection of prostate cancer is based on the PSA level of blood. This inexpensive monitoring method can be repeated quite often compared to the empirical propagation velocity of the disease. The disadvantage of this test is that besides tumour other factors may also increase the PSA level (e.g. inflammation), therefore the number of false positive results is high [1] .
Introduction
The prostate cancer is one of the most common male tumorous disease. The disease is generally indolent, plus the detection and treatment at an early stage results high proportion of cured patients or improved quality of life.
Those materials, which pointing to the existence of cancer called tumour markers. The tumour markers are verified by laboratory tests, or are tried to isolate the high-risk cases with screening -depending on the type of cancer.
For screening those laboratory method are suitable, which are cost-effective, easy to implement, and sufficiently sensitive and specific -that helps to distinguish the clinically significant cases from the insignificants.
The prostate cancers are often used to indicate with the following tests. 1. The PSA level test measures the presence of prostate-specific antigen (this antigen is a tumour marker) from blood sample. This procedure carried out cheaply (10-12 EUR in 2014), therefore currently this is the most widely used screening. The investigation has the disadvantage that beyond cancer other reasons also raise the PSA level, so the process could over diagnose -about 20% of the positive results are false-positive.
2. During the digital rectal examination (DRE test) the urologist checks the prostate through the rectum and looking for differences.
3. The PCA3 level test is a genetic test that measures the level of the PCA3 gene. This gene (which is also a tumour marker) is only detectable in the prostate tissue and therefore the sensitivity of the process exceeds the monitoring of PSA level test. The false-positive alerts only about 10% of the total positive tests. However, the procedure is also costly (235-250 EUR in 2014).
In case of symptoms of prostate cancer the general protocol starts with a DRE test and simultaneously a PSA level test. According to the PSA level -and beyond the emergency surgery -the next step could be a prostate biopsy, an active follow of the patient's PSA level with annual tests, or the end of the protocol in a negative case. This protocol is generally over secured. This causes a lot of unnecessary prostate biopsy. The average cost of such a treatment is around 250-280 EUR in 2014. This raise to a very high amount in a population yearly if we think about the 20% false positive alert of PSA level test. Not to mention the additional risks of such an invasive treatment, especially in case of an elder man. In this paper we consider only the beginning of this process until the firs treatment, because our vision is a pre-screening aid service for doctors. Further investigation can be found in [3] .
The task
The primary goals are, that after a series of PSA tests to calculate sufficient estimations for the following questions:
1. What is the estimated value of the PSA level in an arbitrary time t?
2. At what t c time reaches the estimated PSA level a predetermined critical value c?
3. What is t d time when the estimated PSA level reaches the double of the last measured value? (In oncology the prostate cancer process is considered booted, when the PSA level doubling time is less than one year.)
4. How will change the current velocity of change of PSA level?
Further goals are to determine the accuracy of the estimations and reduce the number of false positive results of the PSA level test.
Stochastic approach with closed formula
Let t 1 < t 2 < t n the date of the PSA level tests and p 1 , p 2 , p n the measured PSA level for each date (n ∈ IN, n ≥ 3).
Consider the PSA level as stochastic, random variable which depends from the time continuously.
Let F (t) is the expected value of the PSA level at a given t time. Consider the Taylor-series of F (t) up to the third (quadratic) member.
. With these rename look the
quadratic polynomial, which approximates F (t) well near t. An estimation can be created for the a, v and b using the least square method on (t i , p i ) pairs (1 ≤ i ≤ n). The least square method on a quadratic formula works well if there are at least three points, as we originally assumed that n ≥ 3. In our case this means that we should minimise the
formula. This one could solve with the knowledge of that the minimum value is where the a, v and b directional partial derivatives of the above formulas are 0.
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The equations with the partial derivatives are the following:
as well as
To solve this equation system with three equations and three unknown variables introduce the following auxiliary variables
Using these auxiliary variables we can calculate the value of a on this way:
Using the value of a, we can describe the value of v like this:
and finally from a and v we can compute the value of b:
Recursive formula
Adding to the known (t i , p i ) coordinate pairs a new (t n+1 , p n+1 ) one (1 ≤ i ≤ n, n ≥ 3) recursive formulas can be used for simpler and smarter model. This recursive approach is a natural improvement based on the computational method of the A 0 , A 1 , . . . , D 2 auxiliary variables.
In the beginning we should determine the a = a 3 , v = v 3 , and b = b 3 coefficients with the above described closed version of least square method from the first three given points. When the new coordinate pair is added to the series (n > 3), then we can calculate recursively for each steps the a 4 , a 5 , . . . , a n , v 4 , v 5 , . . . , v n , and b 4 , b 5 , . . . , b n coefficients. Of course this approach uses the indexed version of the auxiliary variables as the following
n+1
From these in each steps the Due to the very sensitive nature of the least square method from a certain n, we can use the averages of the previous a i , v i and b i coefficients like this (3 ≤ i ≤ n+1):
Because the least square method assumes homogenous data series this can compensate the distorting effect of a very different (t i , p i ) coordinate pair.
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Conclusions
With the knowledge of these parameters we can count the t c , and t d times. The
a will satisfy the requirements from a time value. This t c result based on the c critical value, which depends from the age and race of the person.
This t c time shows when the estimated PSA level will exceed the c critical value (c > 0). In the international literature the European standard for the critical values are in Table 1 Table 1 The This time indicates when the estimated PSA level will exceed the double of the last measured p n PSA value. If the t d −t n difference is shorter than a year then the tumorous process is considered booted. (This booted phase can occurs between the (t i , p i ) pairs (1 ≤ i ≤ n, n ≥ 3), when p j > 2p i and t j − t i < 1 (1 ≤ i < j ≤ n, n ≥ 3).) In the following in this paper we concentrate only for those cases when the booted phase is not reached before the time of the last PSA level test.
The current velocity of the change countable with thė
formula. Here the acceleration of the PSA level raising is described with thë This code is using the closed equation without any investigation of variables or pre-conditions. Taking care on the values a, v and b parameters needs further improvements, The improved version of this algorithm produces the output on Fig. 2 .
On this output we can see the entered values, the approximation polynomial with the special times and a few estimated PSA values ahead in time. The medical interpretation of the calculated value is currently under investigation. This is the fundament of the algorithms in PRO-FILTER. There are more discussion about the additional parameters, and conditions in [3] .
